Business Context and Reporting Period
Company: TTM Technologies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 1, 2024
Event: Entry into a Material Definitive Agreement regarding debt refinancing.
Key Financial Metrics
This filing reports on a specific debt restructuring event rather than periodic operating results. Key financial figures disclosed include:
- New Term Loan Facility: $346.5 million senior secured term loan.
- Interest Rate: Floating rate of 1-month CME Term SOFR plus 2.25%.
- Transaction Costs: Estimated fees and expenses of approximately $1.0 million.
- Maturity Date: May 30, 2030.
Note: The filing does not provide current revenue, profit, cash flow, or total debt levels outside of the specific facility being amended.
Material Changes Versus Prior Period
The Company amended and restated its existing 2023 Term Loan Facility. The primary material changes are:
- Refinancing: The new facility refinances the full amount of outstanding indebtedness under the 2023 Term Loan Facility.
- Interest Rate Reduction: The applicable margin was reduced by 50 basis points (from 2.75% to 2.25% over SOFR).
- Terms: The scheduled maturity date remains unchanged at May 30, 2030.
Guidance, Outlook, and Risks
Management Commentary: Management executed this amendment to secure a lower interest rate margin while maintaining the existing maturity profile. The full text of the Amendment will be included as an exhibit to the next Quarterly Report on Form 10-Q.
Risks and Contingencies: The filing notes the incurrence of approximately $1.0 million in immediate fees and expenses. No other specific risks or contingencies were detailed in this summary section.
Investor Verification Checklist
- Verify the exact outstanding principal balance of the 2023 Term Loan Facility prior to refinancing to confirm the $346.5 million figure covers the full amount.
- Review the upcoming Form 10-Q for the full text of the Amendment to understand any covenant changes not summarized here.
- Monitor the impact of the $1.0 million transaction fee on the Company's current quarter cash flow.
- Confirm the current 1-month CME Term SOFR rate to calculate the effective interest cost immediately following the amendment.